Vitamin D (VitD) deficiency is considered a global problem and might be associated with increased susceptibility to COVID-19 illness. In the light of COVID-19 pandemic, VitD might be a promising agent for fighting the SARS-CoV-2, since VitD is involved in various pathophysiological mechanisms that occur during COVID-19 infection. High-dose VitD supplementation, particularly for risk groups, could be recommended to achieve and maintain optimal (range 40-60 ng/mL) serum 25-hydroxy vitamin D levels (marker of VitD status) both for COVID-19 prevention and treatment. © 2020 John Wiley & Sons Ltd.
Andrius Bleizgys. Vitamin D and COVID-19: It is time to act. International journal of clinical practice. 2021 Mar;75(3):e13748
PMID: 33012103
View Full Text